and as they also lead to inflammation, that increased number ends up providing a hotbed for cancer and all sorts of disease. so, biotech companies are trying to create drugs that will reduce that cellular senescence. i m adding my reagent to the eye tissue, so that i can understand which types of cells are senescent. unity is using this science and it s now achieved small early stage clinical trials for eye injections to treat macular degeneration that s failing eyesight that glasses can t fix. we re able to stain the senescent cells purple, so that i can visualise spatially, within the eye, where the senescent cells reside. once you get rid of one of these cells, it s gone. this would be a small number of treatments over a limited amount of time.
so, biotech companies are trying to create drugs that will reduce that cellular senescence. i m adding my reagent to the eye tissue so that i can understand which types of cells are senescent. unity is using this science and it s now achieved small early stage clinical trials for eye injections to treat macular degeneration that s failing eyesight that glasses can t fix. we re able to stain the senescent cells purple, so i can visualise spatially within the eye where the senescent cells reside. once you get rid of one of these cells, it s gone. this would be a small number of treatments over a limited amount of time. one of the things we ve started to see is that because the fda
was the ability to reduce what are called senescent cells. these zombie cells play a useful role throughout our lifetime but as we age, we acquire many more, and as they also lead to inflammation, that increased number ends up providing a hotbed for cancer and all sorts of disease. so biotech companies are trying to create drugs that will reduce that cellular senescence. i m adding my reagent to the eye tissue so i can understand which types of cells are senescent. unity is using this science, and it has now achieved small early stage clinical trials for eye injections to treat macular degeneration that is failing eyesight that glasses can t fix.
Integra Biosciences introduces a game-changing solution to enhance cell-based workflows with the innovative WELLJET reagent dispenser and EasySnap™ dispensing cassettes. Click to read more.
In this application note, Evik Diagnostics introduces its EVIK Lyophilized Master Mix Reagent Beads, which streamline the development of stable, durable, and reproducible molecular diagnostic assays. These beads reduce the risk of assay failure in sensitivity and stability, save time and costs by eliminating the need for enzyme and excipient selection, and significantly shorten the project timelines for process development, validation, and device assays. By utilizing EVIK qPCR Master Mix Beads,